Breaking News

Ottawa signs $40M deal with Saskatchewan to offer drug coverage for rare diseases


Canada

Minister of Health Mark Holland speaks at the National Press Theatre in Ottawa, on Wednesday, July 17, 2024. THE CANADIAN PRESS/Justin Tang.

JDT



Share this item via WhatsApp


The Saskatchewan and federal governments have announced an agreement for coverage of select new drugs for rare diseases.

Ottawa says the plan is to invest more than $40 million to cover three drugs that treat certain cancers and a urinary issue.

The medicines are Poteligeo, Oxlumo and Epkinly.

The agreement is to also see Saskatchewan work with Ottawa and other provinces to develop a plan to improve screening and diagnostics for rare diseases.

Trending Now

Company that processed plant-based milk linked to listeria permanently closes plants

Liberals will get a new leader on March 9, tighten rules for who can vote

Federal Health Minister Mark Holland says the deal helps the health system improve outcomes for those in Saskatchewan with rare diseases.

&copy 2025 The Canadian Press